期刊文献+

基质金属蛋白酶-9在乳腺癌及癌旁正常组织中的表达及意义 被引量:5

Expression of Matrix Metalloproteinase-9 and Its Significance in Breast Carcinoma and Corresponding Non-Tumor Normal Tissues
在线阅读 下载PDF
导出
摘要 目的探讨基质金属蛋白酶-9(MMP-9)在乳腺癌及癌旁正常组织中的表达及意义。方法应用免疫组化S-P法检测50例乳腺癌及癌旁正常组织中MMP-9的表达。结果在乳腺癌中MMP-9的表达明显高于癌旁正常组织(P<0.001),在有淋巴结转移组MMP-9的表达明显高于无淋巴结转移组(P<0.01)。结论MMP-9在乳腺癌组织中有高表达且在乳腺癌细胞突破基底膜向外扩散、转移中起着重要作用。 Objective To approach the expression of matrix metalloproteinase (MMP)-9 and its significance in breast carcinoma and corresponding non-tumor normal tissues. Methods The expression of MMP-9 was observed by S-P immunohistochemical technique in 50 cases with breast carcinomas and corresponding non-tumor normal tissues. Results The expression of MMP-9 in breast cancer was much higher than that in corresponding non-tumor normal tissues (P 〈 0.001 ). Compared with breast carcinomas without positive metastasis, the expression of MMP-9 was up regulated in those with lymph node metastasis( P 〈 0.01).Conclusions MMP-9 may play an important role in the invasion and metastasis of breast cancer.
出处 《肿瘤基础与临床》 2006年第2期113-115,共3页 journal of basic and clinical oncology
基金 四川省宜宾市科技局重点科技项目(200403011)
关键词 乳腺癌 癌旁正常组织 基质金属蛋白酶 breast cancer corresponding non-tumor normal tissues matrix metalloproteinase
  • 相关文献

参考文献9

  • 1卜文,汤钊猷,刘康达,叶胜龙,薛琼.基质金属蛋白酶在肝癌侵袭转移中的作用[J].中华外科杂志,1998,36(9):571-571. 被引量:20
  • 2Maeta H, Ohgi S, Terada T. Protein expression of matrix metalloproteinase 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas [J]. Virchows Arch, 2001,438 (2) : 121 - 128.
  • 3Iwata H, Kobayashi S, lwase H, et al. Production of matrix matalloproteinase and tissue inihibitors of matallopmteinase in human breast carcinomas [J] .Jpn J Cancer Res, 1996,87(6) :602- 611.
  • 4Aznavoorian S, Murphy AN, Stetler Stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis[J]. Cancer, 1993,71 (4) : 1368- 1383.
  • 5Shimizu M, Saitoh Y,Itoh H.Immunohistochemical staining of Ha-ras oneogene product in normal, benign and malignant human pancreatic tissues[J]. Hum Pathol, 1990,21 (6) :607 - 612.
  • 6Mantovani A, Bottazi B, Colotta F, et al. The origin and function of tumor-associated macrophages [J].Immunol Today, 1992,13(7):265 - 270.
  • 7Zucker S, Lysik RM, Zarrabi MH, et al. M(r)92,000 type Ⅳ collagenase is increased in plasma of patients with colon cancer and breast cancer[J]. Cancer Res, 1993,53(1):140 - 146.
  • 8何旭,李玉林,张丽红.基质金属蛋白酶及其抑制剂在乳腺癌中的表达及意义[J].吉林大学学报(医学版),2003,29(6):753-755. 被引量:16
  • 9赵颖海,苟新敏,陈小毅,李飞虹,蔡琼珍.乳腺良性病变及乳腺癌组织中基质金属蛋白酶-2、-9的表达及其意义[J].广东医学院学报,2002,20(4):251-252. 被引量:2

二级参考文献10

  • 1Liotta LA,Steeg PS,Stetler-Stevenson WG.Cancer metastasis andangiogenesis: an imbalance of positive and negative regulation.Cell,1991,64:327-336
  • 2Zeng ZS, Guillem J G. Distinct pattern of matrix metalloproteinase 9 and tissueinhibitor of metalloproteinase 1 mRNA expression in human colorectal canc er andliver metastases. Br J Cancer,1995,72:575-582
  • 3Naylor MS,Stamp GM,Davies BD,et al.Expression and activity of MMPs and theirregulators in ovarian cancer.Int J Cancer,1994,58∶50-54
  • 4Shimizu M,Satitoh Y.Itoh H.Immunohistochemical staining of Ha-ras oncogene productin normal,benign,and human pancreatic tissues.Hum Pathol.1990,21∶607-612
  • 5Mantovani A,Bottazi B, Colotta F,et al.The origin and function of tumor-asso ciatedmacrophages.Immunol Today,1992,13:265-270
  • 6Maeta H,Ohgi S,Terada T.Protein expression of matrix metalloproteinase 2 and 9 andtissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.VirchowsArch,2001,438(2):121-128
  • 7吴登龙.基质金属蛋白酶及其抑制剂与泌尿系肿瘤的浸润与转移[J].国外医学(泌尿系统分册),1998,18(1):30-33. 被引量:10
  • 8卜文,汤钊猷,刘康达,叶胜龙,薛琼.基质金属蛋白酶在肝癌侵袭转移中的作用[J].中华外科杂志,1998,36(9):571-571. 被引量:20
  • 9王一,徐毅.基质金属蛋白酶[J].医学综述,1999,5(4):174-176. 被引量:8
  • 10贾林,袁世珍,骆福添.胰腺癌MMP-2和TIMP-2表达与预后的关系[J].癌症,1999,18(5):541-544. 被引量:8

共引文献35

同被引文献41

  • 1朱峰,刘新光,梁念慈.三种腺苷类似物抑制人高转移卵巢癌细胞侵袭的实验研究[J].癌症,2004,23(12):1646-1650. 被引量:5
  • 2吕增发,严秦川,刘玉明,王林.原发性肝癌中基质金属蛋白酶表达的临床意义[J].陕西医学杂志,2005,34(6):667-668. 被引量:9
  • 3Pencil SD,Toh Y, Nicolson GL. Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma [J]. Breast Cancer Res Treat,1993,25(2) :165.
  • 4Hamatsu T, Rikimaru T, Yamashita Y, et al. The role of MTA1 gene expression in human hepatocellular carcinoma [J]. Oncol Rep,2003,10(3) :599.
  • 5Furuno K,Takada H ,Yamamoto K, et al. Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease. J Pediatr,2007,151 ( 2 ) : 155.
  • 6Remiszewski SW, Sambucetti LC, Atadja P, et al. Inhibitors of human hidtone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates [ J]. J Med Chem, 2002,45 ( 4 ) : 753.
  • 7Sasaki H, Moriyama S, Nakashima Y, et al. Expression of the MTA1mRNA in the advanced lung cancer[ J]. Lung Cancer,2002,35 ( 2 ) : 149.
  • 8Toh Y, Ohga T, Endo K, et al. Expression of the metastasis- associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas[J]. Int J Cancer,2004,110(3):362.
  • 9Hofer MD,Kuefer R,Varambally S,et al. Expression of MTAI promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells[J]. British J Cancer,2004, 90(2):455.
  • 10Inoue H, Mimori K, Shiraishi T, et al. Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma, Oncol Rep,2000,7 ( 4 ) : 871.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部